Senator Tillis Says U.S. Needs CHIPS Act for Generic Drugs in Short Supply
In Senate hearing: imported generic drugs facing consistent drug shortages need a government incentive program to help labs make life-saving commodity drugs domestically.
Is American Made Medication Preferred Over Imports?
A recent study suggests that Americans prefer locally produced medications if they are unclear where the product was made or if the lab has received bad reviews from an FDA inspection.
India Lab Recalls 27 Eye Drops From U.S. Pharmacies
Another Indian lab recalling eye drops following recalls in October and instances of blindness caused by other imports from India in March.
Congress Can Fix the Dangerous Dependence on Imported Pharmaceuticals
In the wake of the COVID pandemic, consumers have become painfully aware of America’s heavy dependence on imports. The recent Amoxicillin shortage in hospitals has
Loophole in U.S. Customs Law Contributing to Fentanyl Deaths
Last year, more than 73,000 Americans died from an overdose of the synthetic opioid fentanyl. The drug itself is cheap and readily available, with thousands of pounds flowing into
CPA Applauds Congresswoman Tenney’s PILLS Act, Legislation to Boost U.S. Domestic Production of Generic Medicines
WASHINGTON — The Coalition for a Prosperous America (CPA) today applauded the introduction of the Producing Incentives for Long-term Production of Lifesaving Supply of Medicines
U.S. Solar Industry Threatened by China’s Overproduction
Chinese solar manufacturers could take advantage of the Inflation Reduction Act’s tax credits by opening plants in the United States.
Written Testimony Before The House Homeland Security Subcommittee on Oversight, Investigations, and Accountability: Exploitation And Enforcement: Evaluating the Department of Homeland Security’s Efforts to Counter Uyghur Forced Labor
The following written testimony was submitted by Michael Stumo, CEO of CPA, to the House Homeland Security Subcommittee on Oversight, Investigations, and Accountability in a
Government Incentives Needed To Reshore Critical Supply Chains, From Pharmaceuticals to Minerals
The U.S. China Economic & Security Review Commission heard from witnesses about keeping auto tariffs on China, and more incentives for manufacturing to reshore.
Falsehoods & Facts: The Truth About De Minimis
Background De minimis is a regulatory loophole. It was morphed from a tiny customs administrative exception into a backdoor superhighway through our ports. The regulatory
